Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian Cancer
NCT00189579 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2007-08-17
Summary
The purpose of this study is to evaluate whether or not the addition of Herceptin may be of benefit to a standard regimen of carboplatin-paclitaxel.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
- collaborator INDUSTRY
-
ARCAGY/ GINECO GROUP
lead OTHER
Principal Investigators
-
Eric Pujade-Lauraine, MD, PhD · Hopital Hotel-Dieu
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Completion
- 2007-01-31
Countries
- France
Study Locations
More Related Trials
-
Platinum-based Chemotherapy With Atezolizumab and Niraparib in Patients With Recurrent Ovarian Cancer
NCT03598270 ·Status: COMPLETED ·Phase: PHASE3
-
Slowed Carboplatin Infusion for Ovarian Cancer Patients Receiving Carboplatin Re-Treatment
NCT02035345 ·Status: TERMINATED ·Phase: PHASE4
-
Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval
NCT00657878 ·Status: UNKNOWN ·Phase: PHASE3
-
Study on Decitabine Plus Carboplatin Versus Physician's Choice Chemotherapy in Recurrent, Platinum-resistant Ovarian Cancer.
NCT03467178 ·Status: UNKNOWN ·Phase: PHASE2
-
Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer
NCT00102414 ·Status: COMPLETED ·Phase: PHASE3
-
Erlotinib Plus Carboplatin and Paclitaxel in Ovarian Carcinoma
NCT00059787 ·Status: COMPLETED ·Phase: PHASE2
-
Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal Cancer
NCT00004037 ·Status: TERMINATED ·Phase: PHASE2
-
Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer
NCT01680575 ·Status: UNKNOWN
-
Tolerance of Intraperitoneal (IP) Nivolumab After Extensive Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Ovarian Carcinoma
NCT03959761 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study of Docetaxel and Carboplatin in Late Relapse of Ovarian Cancer
NCT02026921 ·Status: COMPLETED ·Phase: PHASE2
-
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study
NCT00968799 ·Status: TERMINATED ·Phase: NA
-
Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity Cancer
NCT00006812 ·Status: TERMINATED ·Phase: PHASE2
-
Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery
NCT04498117 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
NCT00075543 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
HOT: HIPEC in Ovarian Cancer as Initial Treatment
NCT02124421 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian Cancer
NCT02004093 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer
NCT02383251 ·Status: COMPLETED ·Phase: PHASE2
-
A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
NCT01570582 ·Status: UNKNOWN ·Phase: PHASE2
-
Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer
NCT00217529 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
NCT06055348 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Reinduction Chemotherapy Containing Carboplatin and Paclitaxel With or Without Epoetin Alpha in Recurrent Platinum Sensitive Ovarian Cancer, Cancer of the Fallopian Tube or Peritoneum
NCT00189371 ·Status: TERMINATED ·Phase: PHASE3
-
Irinotecan and Bevacizumab for Recurrent Ovarian Cancer
NCT01091259 ·Status: COMPLETED ·Phase: PHASE2
-
Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer
NCT02199171 ·Status: COMPLETED ·Phase: PHASE1
-
Study Comparing Weekly Versus Every 3 Week Chemotherapy in Patients With Ovarian Cancer
NCT00660842 ·Status: UNKNOWN ·Phase: PHASE3
-
Dose-finding Study in Platinum-Resistant Ovarian Cancer
NCT01653912 ·Status: COMPLETED ·Phase: PHASE1/PHASE2